| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.4 | 0.03 |